Back
Altimmune 10K Form
Sell
41
ALT
Altimmune
Last Price:
7.22
Seasonality Move:
43.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALT News And Ratings
See the #1 stock for the next 7 days that we like better than ALT
ALT Financial Statistics
Sales & Book Value
| Annual Sales: | $426K |
|---|---|
| Cash Flow: | $-16.53M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.75 |
| Price / Book: | 2.63 |
Profitability
| EPS (TTM): | -1.67000 |
|---|---|
| Net Income (TTM): | $-88.45M |
| Gross Margin: | $17.91M |
| Return on Equity: | -51.11% |
| Return on Assets: | -46.33% |
Altimmune Earnings Forecast
Key Altimmune Financial Ratios
- The Gross Profit Margin over the past 9 years for ALT is 100.00%.
- The Selling, General & Administrative Expenses for ALT have been equal to 4,257.51% of Gross Profit Margin.
- The Research & Development expenses have been 15,445.77% of Revenue.
- The Interest Expense is -0.04% of Operating Income.
- The Net Earning history of ALT is -20,762.21% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 11 years.
Altimmune Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALT |
| CUSIP: | 02155H |
| Website: | altimmune.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 17.26 |
| Quick Ratio: | 16.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |